Information title

Merck invests $300M in vaccine expansion; Bayer taps new chief;

Published on Friday 25 July 2008 - 15:03

Summary :
> Merck's decision to pump $300 million into an expansion of its Durham, NC vaccine facility is seen by analysts as part of a coordinated effort to solidify a leading role in a booming global...
Read more

Information source

http://www.fiercebiotech.com/news/frontpage

Website description
Get the latest news on the biotech industry, biotech companies, FDA approval and clinical research. Sign up today for the biotech industry

Articles published on this website : 1 / 7 days - 8 / 30 days

ProteoStasis secures $45M in first round

Nasdaq warns Oncothyreon; ATS buys majority share of

JPMorgan steps in for Myriad Genetics review

Century-old drug may slow aging

Pfizer inks vaccine pact with Cytos

Other articles published on other websites on the same day

Alzheimer's: Have Many Grains of Salt Ready

http://blog.newsweek.com/

Putting a Price on Innovation

http://www.portfolio.com/

New Alzheimer's drug inspires hope

http://www.stuff.co.nz/

Letter to the Editor

http://www.greene-news.com/

The Friday Buffet

http://chicagoist.com/

ICAD 2008: Alzheimer's Association International Conference on Alzheimer's Disease

http://www.medscape.com/

A Bad Mix - Cell Phones and Children?

http://brainblogger.com/

Alzheimer's & Dementia: The Journal of the Alzheimer's Association Accepted for...

http://www.webwire.com/

Neurotherapeutics Presents Special Issue on New Treatments for Alzheimer's Disease

http://www.webwire.com/

Alvaro Fernandez: Top 10 Brain Training Predictions

http://www.huffingtonpost.com/